使用SonoVue和Sonazoid的超声造影LI-RADS诊断肝细胞癌:一项单中心前瞻性研究
该单中心前瞻性研究纳入66例肝细胞癌高危患者共66个肝脏病灶,均行SonoVue-CEUS和Sonazoid-CEUS检查,分别按CEUS LI-RADS v2017和整合Kupffer期表现的改良Sonazoid-CEUS LI-RADS分类,以病理为参考标准。Sonazoid-CEUS LI-RADS较SonoVue-CEUS LI-RADS敏感度(82% vs. 65%,p < 0.001)和准确率(85% vs. 71%,p < 0.001)显著提高,特异度(93% vs. 87%,p = 0.26)无显著差异。
要点
- Sonazoid-CEUS LI-RADS较SonoVue-CEUS LI-RADS敏感度82% vs. 65%(p < 0.001),准确率85% vs. 71%(p < 0.001)。
- 特异度93% vs. 87%(p = 0.26),两者无显著差异。
- 改良算法:≥10 mm非环状动脉期高增强病灶,无廓清伴Kupffer缺损由LR-4升级为LR-5;早期廓清伴轻度Kupffer缺损由LR-M改为LR-5。
核心结论
- 整合Kupffer期表现后,Sonazoid-CEUS LI-RADS较SonoVue-CEUS LI-RADS敏感度更高且未损失特异度。
研究设计与样本
- 单中心前瞻性研究,纳入肝细胞癌高危患者66例共66个病灶(平均年龄61.2岁±10.9,男54例、女12例,病灶平均大小31 mm±16),每例均行SonoVue-CEUS和Sonazoid-CEUS,以病理确诊为参考标准。
诊断标准与关键数值
- SonoVue-CEUS按CEUS LI-RADS 2017版分类;Sonazoid-CEUS采用改良算法:≥10 mm且非环状动脉期高增强的病灶,无廓清伴Kupffer缺损由LR-4升级为LR-5,早期廓清伴轻度Kupffer缺损由LR-M改为LR-5。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the diagnostic performance of two algorithms for HCC diagnosis: SonoVue-CEUS based on CEUS LI-RADS version 2017 and a modified algorithm incorporating Kupffer-phase findings for Sonazoid-CEUS.
METHODS: This single center prospective study enrolled high-risk patients for HCC. Each participant underwent SonoVue-CEUS and Sonazoid-CEUS. Each liver observation was assigned two LI-RADS categories according to each algorithm: SonoVue-CEUS LI-RADS and modified Sonazoid-CEUS LI-RADS. For the latter method, observations at least 10 mm with non-rim arterial phase hyperenhancement were upgraded LR-4 to LR-5 if there was no washout with a Kupffer defect and were reassigned LR-M to LR-5 if there was early washout with mild Kupffer defect. The reference standard was pathologic confirmation.
RESULTS: Overall, 66 patients (mean age, 61.2 years ± 10.9; 54 male patients, 12 female patients) with 66 observations (mean size, 31 mm ± 16) were eventually enrolled. The results of Sonazoid-CEUS LI-RADS showed significant changes in sensitivity (82% vs. 65%, p < 0.001), accuracy (85% vs. 71%, p < 0.001) compared with the SonoVue-CEUS LI-RADS. There was no significant difference in specificity (93% vs. 87%, p = 0.26).
CONCLUSION: When incorporating Kupffer-phase findings, Sonazoid-CEUS LI-RADS had higher sensitivity without loss of specificity compared with SonoVue-CEUS LI-RADS.
引用
- Lin C, Yang XH, Zhai HY, et al. LI-RADS for diagnosing hepatocellular carcinoma by contrast-enhanced US with SonoVue and Sonazoid-a single center prospective study. Abdom Radiol (NY). 2025. PMID: 40116886. doi:10.1007/s00261-025-04881-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。